logo

For the Inventor, By the Inventor

Vosselaar, Belgium

Albert H Van Heertum

USPTO Granted Patents = 14

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 213(Granted Patents)


Company Filing History:

goldMedal14 out of 2,081 
 
Janssen Pharmaceutica Nv
 patents

Years Active: 1976-1985

Loading Chart...
14 patents (USPTO):Explore Patents
1. 4522945 - (Piperidinylalkyl) quinazoline derivatives (1985-06-11),
2. 4377578 - Piperazine derivatives (1983-03-22),
3. 4335127 - Piperidinylalkyl quinazoline compounds, composition and method of use (1982-06-15),
4. 4254127 - 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives (1981-03-03),
5. 4250176 - Piperazine derivatives (1981-02-10),
6. 4200641 - 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives (1980-04-29),
7. 4175129 - Antiemetic 1-(benzoxazolylalkyl)-piperidine derivatives (1979-11-20),
8. 4160836 - Antiemetic 1-(benzothiazolylalkyl)piperidine derivatives (1979-07-10),
9. 4126688 - Antiemetic 1-(benzotriazolyl-alkyl)-piperidine derivatives (1978-11-21),
10. 4126687 - Antiemetic, 1-(benzimidazolyl-alkyl)-piperidine derivatives (1978-11-21),
11. 4110333 - 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and (1978-08-29),
12. 4066772 - 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and (1978-01-03),
13. 4035369 - 1-Benzazolylalkyl-4-substituted-piperidines (1977-07-12),
14. 3989707 - Benzimidazolinone derivatives (1976-11-02),

Title: Innovative Contributions of Albert H. Van Heertum

Introduction

Albert H. Van Heertum, an accomplished inventor based in Vosselaar, Belgium, has made significant contributions to the field of medicinal chemistry through his innovative work. With a remarkable portfolio of 14 patents, he has developed novel compounds aimed at addressing various medical needs, particularly in the areas of serotonin antagonism and antihistaminic properties.

Latest Patents

Among Van Heertum's latest innovations are the patents for (Piperidinylalkyl) quinazoline derivatives and Piperazine derivatives. The first patent outlines the development of novel quinazoline derivatives that feature at least one carbonyl or thiocarbonyl group within their structure, complemented by a specifically substituted piperidinyl-alkyl side chain. These compounds have been identified as potent serotonin antagonists, showcasing their potential therapeutic applications. The second patent focuses on novel 1-substituted 4-(diarylmethyl)piperazine derivatives, which possess antianaphylactic and antihistaminic properties, further contributing to the advancement of medical treatments.

Career Highlights

Albert H. Van Heertum has built a distinguished career at Janssen Pharmaceutica, a prominent company in the pharmaceutical sector. His work has not only led to innovative patent filings but has also advanced the understanding of complex chemical interactions in medicinal applications.

Collaborations

Throughout his career, Van Heertum has collaborated with notable colleagues such as Jan Vandenberk and Marcel J. Van der Aa. These collaborations have enriched his research and development efforts, leading to successful innovations that have a meaningful impact in the pharmaceutical landscape.

Conclusion

Albert H. Van Heertum stands out as a significant inventor whose work at Janssen Pharmaceutica continues to shape the future of medicinal chemistry. With his impressive array of patents and collaborative spirit, he remains a key figure in the advancement of innovative therapies. His contributions will undoubtedly leave a lasting legacy in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…